Bergstrom S, Carr H, Petersson G, et al: Trends in congenital heart defects in infants with Down syndrome. Pediatrics 138(1):e210160123, 2016 Bianchi OW, Chudova 0, Sehnert AJ, et al: Noninvasive prenatal testing and incidental detection of occult malignancies. JAMA 314(2):162,o2015 Bianchi OW, Hanson J: Sharpening the tools: a summary of a National Institutes of Health workshop on new technologies for detection of fetal cells in maternal blood for early prenatal diagnosis. J Matern Fetal Neonatal Med 19(4):199,o2006 Blau N, van Spronsen FJ, Levy HL: Phenylketonuria. Lancet 376(9750):1417, 20o10 Boada R, Janusz J, Hutaf-Lee C, et al: he cognitive phenotype in Klinefelter syndrome: a review of the literature including genetic and hormonal factors. Dev Disabil Res Rev 15(4):284,o2009 Bui TH, Iselius L, Lindsten J: European collaborative study on prenatal diagnosis: mosaicism, pseudomosaicism and single abnormal cells in amniotic fluid cultures. Prenat Diagn 4(7):145,o1984 Bull MJ, American Academy of Pediatrics Committee on Genetics: Health supervision for children with Down syndrome. Pediatrics 128(2):393, 2011 Burn J, Brennan P, Little J, et al: Recurrence risks in ofspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet 351 (9099):311, 1998 Callaway JL, Shafer LG, Chitry LS, et al: he clinicaloutiliry of microarray technologies applied to prenatal cytogenetics in the presence of a normal conventional karyotype: a review of the literature. Prenat Diagn 33(12): 1119,o2013 Carey L, Scott F, Murphy K, et al: Prenatal diagnosis of chromosomal mosaicism in over 1600 cases using array comparative genomic hybridization as a first line test. Prenat Diagn 34(5):478, 2014 Chitty LS, Finning K, Wade A: Diagnostic accuracy of routine antenatal determination of fetal RHO status across gestation: population based cohort study. BMJ 349:g5243, 2014 Clausen FB, Christiansen M, Stefensen R, et al: Report of the first nationally implemented clinical routine screening for fetal RHO in 0-pregnant women to ascertain the requirement for antenatal RHO prophylaxis. Transfusion 52(4):752, 2012 Cockwell A, MacKenzie M, Youings S, et al: A cytogenetic and molecular study of a series of 45,X fetuses and their parents. J Med Genet 28(3): 151, 1991
Cools M, Pleskacovao], Stoop H, et al: Gonadal pathology and tumor risk in relation to clinical characteristics in patients with 45,XJ46,XY mosaicism. ] Clin Endocrinol Metab 96( ):Elo171, 2011
Cragan ]0, Gilboa SM: Including prenatal diagnoses in birth defects monitoring: experience of the Metropolitan Atlanta Congenital Defects Program. Birth Defects Res A Clin Mol Teratol 85(1):20, 2009